X-154309384-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP3BS2
The NM_012253.4(TKTL1):āc.292C>Gā(p.Gln98Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000132 in 1,209,791 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000054 ( 0 hom., 1 hem., cov: 22)
Exomes š: 0.0000091 ( 0 hom. 4 hem. )
Consequence
TKTL1
NM_012253.4 missense
NM_012253.4 missense
Scores
6
7
4
Clinical Significance
Conservation
PhyloP100: 7.66
Genes affected
TKTL1 (HGNC:11835): (transketolase like 1) The protein encoded by this gene is a transketolase that acts as a homodimer and catalyzes the conversion of sedoheptulose 7-phosphate and D-glyceraldehyde 3-phosphate to D-ribose 5-phosphate and D-xylulose 5-phosphate. This reaction links the pentose phosphate pathway with the glycolytic pathway. Variations in this gene may be the cause of Wernicke-Korsakoff syndrome. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.793
BS2
High Hemizygotes in GnomAdExome4 at 4 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TKTL1 | NM_012253.4 | c.292C>G | p.Gln98Glu | missense_variant | 3/13 | ENST00000369915.8 | NP_036385.3 | |
TKTL1 | NM_001145933.2 | c.274C>G | p.Gln92Glu | missense_variant | 3/13 | NP_001139405.1 | ||
TKTL1 | NM_001145934.2 | c.124C>G | p.Gln42Glu | missense_variant | 2/12 | NP_001139406.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TKTL1 | ENST00000369915.8 | c.292C>G | p.Gln98Glu | missense_variant | 3/13 | 1 | NM_012253.4 | ENSP00000358931 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000537 AC: 6AN: 111679Hom.: 0 Cov.: 22 AF XY: 0.0000295 AC XY: 1AN XY: 33857
GnomAD3 genomes
AF:
AC:
6
AN:
111679
Hom.:
Cov.:
22
AF XY:
AC XY:
1
AN XY:
33857
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000327 AC: 6AN: 183438Hom.: 0 AF XY: 0.0000295 AC XY: 2AN XY: 67872
GnomAD3 exomes
AF:
AC:
6
AN:
183438
Hom.:
AF XY:
AC XY:
2
AN XY:
67872
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000911 AC: 10AN: 1098060Hom.: 0 Cov.: 30 AF XY: 0.0000110 AC XY: 4AN XY: 363414
GnomAD4 exome
AF:
AC:
10
AN:
1098060
Hom.:
Cov.:
30
AF XY:
AC XY:
4
AN XY:
363414
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000537 AC: 6AN: 111731Hom.: 0 Cov.: 22 AF XY: 0.0000295 AC XY: 1AN XY: 33919
GnomAD4 genome
AF:
AC:
6
AN:
111731
Hom.:
Cov.:
22
AF XY:
AC XY:
1
AN XY:
33919
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 08, 2022 | The c.292C>G (p.Q98E) alteration is located in exon 3 (coding exon 3) of the TKTL1 gene. This alteration results from a C to G substitution at nucleotide position 292, causing the glutamine (Q) at amino acid position 98 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;.
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
H;.;.
MutationTaster
Benign
D;D;D
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D;D
REVEL
Uncertain
Sift
Pathogenic
D;D;D
Sift4G
Pathogenic
D;D;D
Polyphen
D;.;.
Vest4
MutPred
Loss of helix (P = 0.1299);Loss of helix (P = 0.1299);.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at